Latest Industry Updates
From company milestones to industry breakthroughs, uncover the stories making waves and shaping the narrative in real time.
- Featured Article
As AI finds solid footing in pharma R&D, the technology is slated to yield significant rewards....
Source: PharmaVoice
- Featured Article
To kick off 2026, we spoke with industry experts and leaders in the Clinical Research News...
Source: Clinical Research News
- Featured Article
Dan Beaudry, market owner for risk-based quality management (RBQM) at CluePoints, explains how regulatory shifts and...
Source: Discover Pharma
- Featured Article
Returning to the series is CluePoints, with Sophie Henderson, senior strategic consultant, sharing her hopes and...
Source: Discover Pharma
- Featured Article
Regulatory changes, including the launch of ICH E6(R3) and Good Clinical Practice (GCP) updates, have highlighted...
Source: International Pharmaceutical Industry
- Featured Article
Sophie Henderson, Senior Strategic Consultant at CluePoints, said: “This year we have seen risk-based quality management...
Source: Discover Pharma
- Press Release
CluePoints Scoops Prestigious 2025 Scrip Award RBQM and AI leader wins the ‘Best Contract Research Organization...
- Press Release
King of Prussia, PA – November 5th, 2025: CluePoints, provider of leading statistical and AI-driven software...
- Featured Article
As clinical trials become more complex, leading sponsors are shifting the focus of their clinical research...
Source: The Association of Clinical Research Professionals
- Featured Article
Source: Applied Clinical Trials
- Press Release
The RBQM and AI leader wins the ‘Clinical Data Science Implementation Excellence Award’ at SCDM 2025...
- Press Release
KING OF PRUSSIA, Pa., Sept. 23, 2025 /PRNewswire/ — CluePoints, the premier sponsor of RBQMLive and...
- Press Release
King of Prussia, PA: RBQM leader, CluePoints, has today announced that Amit Patel will join as...
- Press Release
King of Prussia, PA – March 23rd, 2023: CluePoints, the premier provider of Risk-Based Study Execution...
- Press Release
Authors: Steve Young, Chief Scientific Officer Sylviane de Viron, Data and Knowledge Manager In the face...
- Press Release
King of Prussia, PA – 6 February 2023: CluePoints, the premier provider of Risk-Based Study Execution...
- Press Release
King of Prussia, PA – December 13, 2022: RBQM leader, CluePoints, has today announced Andy Cooper...
- Press Release
King of Prussia, PA – October 12th, 2022: Risk-based quality management (RBQM) solutions provider, CluePoints, is...
- Press Release
According to CluePoints Senior Vice President John Hall, “Federated learning is a critical evolution in the...
- Press Release
King of Prussia, PA – April 11, 2022: CluePoints, the premier provider of Risk-Based Study Execution...
- Press Release
King of Prussia, PA – April 5, 2022: CluePoints, the premier provider of Risk-Based Study Execution...
- Press Release
King of Prussia, PA – 7th March 2022: CluePoints, the premier provider of Risk-Based Study Execution...
- Press Release
John Hall, Senior Vice President, EU, and APAC, at CluePoints, will share insights into delivering successful...
- Press Release
King of Prussia, PA: Harvest Integrated Research Organization (HiRO), a Shanghai-based Clinical Research Organization (CRO), has...
- Featured Article
The pharmaceutical industry has a problem – a failure to provide women with C-suite opportunities.
...Source: International Clinical Trials
- Featured Article
The ICH E6(R3) draft guideline document, currently open to public consultation, places the industry firmly in...
Source: Applied Clinical Trials
- Featured Article
Despite the push for greater use of risk-based quality management (RBQM) in clinical research, adoption of...
Source: CenterWatch
- Featured Article
Central monitoring aims to detect emerging quality-related risks proactively during a clinical trial, resulting in study...
Source: Applied Clinical Trials
- Featured Article
Using key risk indicators (KRIs) can improve clinical trial data quality in 80% of the sites...
Source: Applied Clinical Trials
- Featured Article
Since the release of ICH E6(R2), multiple efforts have been made to interpret the requirements and...
- Read
Source: Springer Link
- Featured Article
An expectation for the use of quality tolerance limits (QTLs) was formally established in the International...
Source: Applied Clinical Trials
- Featured Article
Clinical research is evolving rapidly, with the digitalization of trials creating a new modus operandi and...
Source: Applied Clinical Trials
- Featured Article
Risk-based approaches to monitoring clinical trials were brought to the forefront with an FDA guidance published...
Source: Applied Clinical Trials
- Featured Article
Key risk indicators (KRIs) are metrics designed to identify risks of specific interest to study teams...
Source: Applied Clinical Trials
- Featured Article
The success of clinical development programmes, drug approval and marketing depends ultimately on the readability and...
Source: International Clinical Trials
- Featured Article
Central monitoring, which typically includes the use of key risk indicators (KRIs), aims at improving the...
Source: Springer Link
